Literature DB >> 26021553

Animal Models of Bone Metastasis.

J K Simmons1, B E Hildreth2, W Supsavhad1, S M Elshafae1, B B Hassan1, W P Dirksen1, R E Toribio2, T J Rosol3.   

Abstract

Bone is one of the most common sites of cancer metastasis in humans and is a significant source of morbidity and mortality. Bone metastases are considered incurable and result in pain, pathologic fracture, and decreased quality of life. Animal models of skeletal metastases are essential to improve the understanding of the molecular pathways of cancer metastasis and growth in bone and to develop new therapies to inhibit and prevent bone metastases. The ideal animal model should be clinically relevant, reproducible, and representative of human disease. Currently, an ideal model does not exist; however, understanding the strengths and weaknesses of the available models will lead to proper study design and successful cancer research. This review provides an overview of the current in vivo animal models used in the study of skeletal metastases or local tumor invasion into bone and focuses on mammary and prostate cancer, lymphoma, multiple myeloma, head and neck squamous cell carcinoma, and miscellaneous tumors that metastasize to bone.
© The Author(s) 2015.

Entities:  

Keywords:  cancer; cat; dog; mammary; osteoblastic; parathyroid hormone–related protein; prostate; squamous cell carcinoma

Mesh:

Year:  2015        PMID: 26021553      PMCID: PMC4545712          DOI: 10.1177/0300985815586223

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  180 in total

1.  HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.

Authors:  Ling Gao; Hongju Deng; Haibo Zhao; Angela Hirbe; John Harding; Lee Ratner; Katherine Weilbaecher
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

2.  Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice.

Authors:  T Miki; S Yano; M Hanibuchi; S Sone
Journal:  Oncol Res       Date:  2000       Impact factor: 5.574

3.  Osteoprotegerin and bone mass in squamous cell head and neck cancer patients.

Authors:  C Valero; J M Olmos; F Rivera; J L Hernández; M E Vega; J González Macías
Journal:  Calcif Tissue Int       Date:  2006-06-21       Impact factor: 4.333

Review 4.  In vivo models of prostate cancer metastasis to bone.

Authors:  Arun S Singh; William D Figg
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

Review 5.  Prostate cancer in dogs: comparative and clinical aspects.

Authors:  Bruce E Leroy; Nicole Northrup
Journal:  Vet J       Date:  2008-09-10       Impact factor: 2.688

6.  An orthotopic murine model of human spinal metastasis: histological and functional correlations.

Authors:  Claudio E Tatsui; Frederick F Lang; Joy Gumin; Dima Suki; Naoki Shinojima; Laurence D Rhines
Journal:  J Neurosurg Spine       Date:  2009-06

7.  Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice.

Authors:  S Cowey; A A Szafran; J Kappes; K R Zinn; G P Siegal; R A Desmond; H Kim; L Evans; R W Hardy
Journal:  Clin Exp Metastasis       Date:  2007-05-31       Impact factor: 5.150

8.  A scatter factor-like factor is produced by a metastatic variant of a rat bladder carcinoma cell line.

Authors:  S Bellusci; G Moens; J P Thiery; J Jouanneau
Journal:  J Cell Sci       Date:  1994-05       Impact factor: 5.285

9.  Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.

Authors:  Elizabeth A Ballegeer; Nicole J Madrill; Kevin L Berger; Dalen W Agnew; Elizabeth A McNiel
Journal:  BMC Cancer       Date:  2013-04-30       Impact factor: 4.430

10.  Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity.

Authors:  M H Driessens; P J Stroeken; N F Rodriguez Erena; M A van der Valk; E A van Rijthoven; E Roos
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more
  50 in total

1.  [Establishment of mouse model of bone metastasis of prostate cancer and breast cancer via femoral artery injection of tumor cells].

Authors:  Zhao-Yang Yin; Si-Yong Qi; Xiang Cheng; Liang Guo; Hong-Yu Chen; Ming Shi
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

2.  Castration Determines the Efficacy of ETAR Blockade in a Mouse Model of Prostate Cancer Bone Metastasis.

Authors:  Henry H Moon; Katrina L Clines; Mark A Cooks; Charlotte A Cialek; Marian A Esvelt; Gregory A Clines
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

3.  Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis.

Authors:  Tong Liu; Svetlana Romanova; Shuo Wang; Megan A Hyun; Chi Zhang; Samuel M Cohen; Rakesh K Singh; Tatiana K Bronich
Journal:  Mol Pharm       Date:  2019-06-14       Impact factor: 4.939

4.  Evaluation of antitumor activity and cardiac toxicity of a bone-targeted ph-sensitive liposomal formulation in a bone metastasis tumor model in mice.

Authors:  Diego Dos Santos Ferreira; Bruno Luís Jesus de Oliveira Pinto; Vidhya Kumar; Valbert Nascimento Cardoso; Simone Odília Fernandes; Cristina Maria Souza; Geovanni Dantas Cassali; Anna Moore; David E Sosnovik; Christian T Farrar; Elaine Amaral Leite; Ricardo José Alves; Mônica Cristina de Oliveira; Alexander Ramos Guimarães; Peter Caravan
Journal:  Nanomedicine       Date:  2017-03-23       Impact factor: 5.307

5.  Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone.

Authors:  Eleonora Dondossola; Stephanie Alexander; Boris M Holzapfel; Stefano Filippini; Michael W Starbuck; Robert M Hoffman; Nora Navone; Elena M De-Juan-Pardo; Christopher J Logothetis; Dietmar W Hutmacher; Peter Friedl
Journal:  Sci Transl Med       Date:  2018-08-01       Impact factor: 17.956

6.  Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer.

Authors:  Maija P Valta; Hongjuan Zhao; Matthias Saar; Johanna Tuomela; Rosalie Nolley; Johannes Linxweiler; Jouko Sandholm; Jaakko Lehtimäki; Pirkko Härkönen; Ilsa Coleman; Peter S Nelson; Eva Corey; Donna M Peehl
Journal:  Clin Exp Metastasis       Date:  2016-02-12       Impact factor: 5.150

7.  A Murine Bone Metastasis Model Using Caudal Artery Injection and Bioluminescence Imaging.

Authors:  Takahiro Kuchimaru; Shinae Kizaka-Kondoh
Journal:  Methods Mol Biol       Date:  2021

8.  Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate.

Authors:  Subrata K Pore; Eun-Ryeong Hahm; Joseph D Latoche; Carolyn J Anderson; Yongli Shuai; Shivendra V Singh
Journal:  Carcinogenesis       Date:  2018-02-09       Impact factor: 4.944

9.  Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis.

Authors:  Cuijuan Yu; Hai Wang; Aaron Muscarella; Amit Goldstein; Huan-Chang Zeng; Yangjin Bae; Brendan H I Lee; Xiang H-F Zhang
Journal:  J Vis Exp       Date:  2016-09-26       Impact factor: 1.355

10.  Feline Mammary Cancer.

Authors:  B B Hassan; S M Elshafae; W Supsavhad; J K Simmons; W P Dirksen; S M Sokkar; T J Rosol
Journal:  Vet Pathol       Date:  2016-07-11       Impact factor: 2.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.